PHARMACEUTICALLY EFFECTIVE COMPOUNDS INHIBITING SELECTIVELY THE MYOSIN 2 ISOFORMS

The present invention relates to compounds of formula (I) or (II), pharmaceutically acceptable salts thereof, solvates, tautomers, and stereoisomers including enantiomers, diastereomers, racemic mixtures, mixtures of enantiomers, or combinations thereof, and the pharmaceutical uses of the compounds. 本发明涉及：式(I)或式(II)的化合物其药学可接受盐、溶剂合物、互变体、立体异构体，所述立体异构体包括对映体、非对映体、外消旋混合物、对映体的混合物、或者它们的组合；以及所述化合物的药学用途。